XYL - Company ID 0001524472
The table below shows Xylem Inc.'s income statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Revenue | $9.04B | $8.56B | $7.36B | $5.52B | $5.20B | $4.88B |
| Cost of revenue | $5.56B | $5.35B | $4.65B | $3.44B | $3.22B | $3.05B |
| Gross profit | $3.48B | $3.21B | $2.72B | $2.08B | $1.98B | $1.83B |
| R&D | $226.00M | $230.00M | $232.00M | $206.00M | $204.00M | $187.00M |
Xylem Inc. reported annual revenue of $9.04B for fiscal year 2025. That is up 5.5% from $8.56B in fiscal 2024. Over the 10 fiscal years shown, annual revenue grew from $3.77B (FY 2016) to $9.04B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| SG&A |
| $1.92B |
| $1.91B |
| $1.76B |
| $1.23B |
| $1.18B |
| $1.14B |
| Operating income | $1.22B | $1.01B | $652.00M | $622.00M | $585.00M | $367.00M |
| Income tax | $231.00M | $197.00M | $26.00M | $85.00M | $84.00M | $31.00M |
| Net income | $957.00M | $890.00M | $609.00M | $355.00M | $427.00M | $254.00M |
| EPS (diluted) | $3.92 | $3.65 | $2.79 | $1.96 | $2.35 | $1.40 |